Novo Nordisk (NVO): Top 10 Large Cap Value Stocks to Buy Now

Novo Nordisk (NYSE:NVO) is one of the top large cap value stocks to buy now. On June 8, Novo Nordisk presented Phase 3 results from its REIMAGINE 1–3 clinical program at the 2026 American Diabetes Association Scientific Sessions. The trials showed that the investigational treatment CagriSem, a once-weekly combination of an amylin analog and a GLP-1 receptor agonist, achieved significant, consistent reductions in both HbA1c levels and body weight across diverse groups of adults with type 2 diabetes.

This combination therapy leverages the synergistic effects of two distinct hormonal pathways to improve glucose regulation and appetite control. Novo Nordisk’s Chief Scientific Officer, Martin Holst Lange, highlighted the therapy’s potential to become a first-in-class treatment option, showing promise for patients at various stages of diabetes management, ranging from initial therapy to insulin add-on.

Novo Nordisk (NVO): Top 10 Large Cap Value Stocks to Buy Now

The findings, simultaneously published in The Lancet and The Lancet Diabetes & Endocrinology, follow previous data from the REDEFINE program. By addressing multiple pathways of metabolic health, the REIMAGINE trials validate the clinical utility of pairing cagrilintide with semaglutide, offering a potential new strategy for patients who may require advanced approaches to managing their diabetes.

Novo Nordisk (NYSE:NVO) is a drug manufacturer for global pharmaceutical products that operates through two segments: Obesity & Diabetes Care and Rare Disease. The company was founded in 1923 and is headquartered in Denmark.

While we acknowledge the risk and potential of NVO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than NVO and that has 10,000% upside potential, check out our report about the cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1